-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

7 Analysts Have This to Say About Globus Medical

Benzinga · 01/06/2023 12:00

Within the last quarter, Globus Medical (NYSE:GMED) has observed the following analyst ratings:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 2 2 3 0 0
Last 30D 0 0 1 0 0
1M Ago 1 1 0 0 0
2M Ago 0 0 1 0 0
3M Ago 1 1 1 0 0

These 7 analysts have an average price target of $74.71 versus the current price of Globus Medical at $71.91, implying upside.

Below is a summary of how these 7 analysts rated Globus Medical over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

price target chart

This average price target has increased by 8.59% over the past month.

Stay up to date on Globus Medical analyst ratings.

How Are Analyst Ratings Determined?

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.